Quest Seeks to Stop Sale of Correlogic's Assets, Claims Rights to OvaCheck IP

In an objection filed last week, Quest asserted that before Correlogic can auction its assets as part of its ongoing bankruptcy proceedings, determination of the extent of Quest's interests in the firm's technology must be "considered in the context of an adversary proceeding."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.